Komipharm International Co., Ltd. manufactures and sells veterinary vaccines, veterinary pharmaceuticals, disinfectants, and bio-fertilizers internationally. It also develops anticancer drugs and pain-relieving agents, including Kominox, an arsenic-based oral drug, and Panaphix, a non-narcotic cancer pain reliever. The company additionally provides clinical pathological experiment, test, and analysis services. Formerly known as Korea Microbiological Laboratories Co., Ltd., it changed its name to Komipharm International Co., Ltd. in September 2004, was founded in 1972, and is headquartered in Siheung, South Korea.